Available studentships
18 PhD studentships available for October 2027 start
Our BBSRC-funded doctoral programme trains students in interdisciplinary approaches to Infection Biosciences across all classes of pathogens, to combat existing and future disease threats to human and animal health, including emerging infections, vector-borne diseases, antimicrobial resistance and food insecurity.
- Funding: Stipend, tuition fees and research costs
- Application deadline: Midday, Monday 11 January 2027
About Wessex One Health (WOH)
WOH brings together the expertise of our three university partners and four major UK institutes with national capability for working on high consequence pathogens, to provide a broad training and research experience for students.
WOH Partners
- University of Surrey (Guildford)
- University of Sussex, including Brighton and Sussex Medical School (Brighton)
- University of Exeter, MRC Centre for Medical Mycology
- The Pirbright Institute (Woking, Surrey)
- Animal and Plant Health Agency (APHA) (Weybridge, Surrey),
- UK Health Security Agency (UKHSA) (Porton Down, Wiltshire or Colindale, London)
- Defence Science Technology Laboratory (Dstl) (Porton Down, Wiltshire)
What we offer
- Wide range of research projects to choose from
- Cross-institutional supervisory teams
- Opportunities to train at high containment
- Cohort training in genomics, bioinformatics, applied AI
- Cohort-building activities across all partners
- Opportunities for studentships working with industry (CASE)
- Wide range of short industrial placement opportunities
Studentship details
All scholarships come with UKRI stipend (currently £21,805 per annum), UK fees and research costs for four years. A small number of international fee waivers will also be available.
In order to be eligible to apply for the necessary security clearance, applicants for projects involving Dstl must be a UK national, currently resident in the UK, and have resided in the UK continuously for the past five years. Applicants for projects including laboratory work at APHA, UKHSA or the Pirbright Institute must be currently resident in the UK and have at least three years' continuous UK residency.
All residency requirements must be met by Monday 11 January 2027 in order to be eligible to apply.
Counter Terrorist Check (CTC) clearance is required prior to commencing work at all the above laboratories. Candidates need to ensure that they are eligible for security clearance. It is up to each person applying for a studentship to ensure they meet the residency criteria. Please contact the supervisors of your chosen project if you have any questions.
Projects involving Dstl, APHA,and UKHSA are subject to specific nationality, residency and security clearance requirements.
If you are interested in a project with one of these organisations and are unsure whether you meet the relevant residency or security clearance criteria, we encourage you to contact the appropriate organisation before applying:
- Dstl projects – Belinda Ameyaw (bameyaw@dstl.gov.uk) or Josh Prince (jprince1@mail.dstl.gov.uk)
- APHA projects – Emma Snary (emma.snary@apha.gov.uk) or Nicholas Johnson (nick.johnson@apha.gov.uk)
- UKHSA projects – Emma Wise (emma.wise2@ukhsa.gov.uk) or Breeze Cavell (breeze.cavell@ukhsa.gov.uk)
Further information on eligibility requirements can be found within the Funding information dropdown. Applicants are responsible for ensuring they meet the relevant criteria before submitting an application.
You will have the ambition, motivation and scientific curiosity to research new approaches to combatting infectious diseases in the following themes:
- Detection, prevention and intervention
- Microbial evolution and drug resistance
- Understanding disease spread
- Infection and cellular biology
You will have, or expect to have, an MSc, and/or a first or upper second-class honours degree in a relevant subject. We welcome applications from graduates of all universities, and from candidates already in employment, or returning after a career break.
Note: Laboratory experience is desirable but not essential, as all successful applicants will be trained in basic laboratory skills where applicable.
Find out more about postgraduate research:
Equity, diversity and inclusion
All partners in Wessex One Health are committed to equity, diversity and inclusion (EDI) and want to ensure that researchers from diverse backgrounds are attracted to our programme. We welcome applications from underrepresented groups and will provide support to help build a research community that reflects the society we serve.
CASE (formerly known as Collaborative Awards in Science and Engineering) studentships enable students to experience enhanced training opportunities directly related to their project.
These three-month (or longer) partnerships allow students to work with a non-academic organisation, such as an industry partner, research institute, technology company, charity or government agency, alongside their academic supervisory team.
CASE studentships can provide:
- Enhanced collaboration with external organisations
- Access to specialist expertise, facilities, data or equipment
- Opportunities to develop professional networks and transferable skills
- Experience of how research informs policy, practice and innovation
- Exposure to career pathways beyond academia
CASE opportunities vary between projects. Look out for 'CASE' within the project title. Details of the CASE partner will be included within the project summary.
Please apply by submitting an application form and completing our EDI survey.
Prospective students are asked to select and rank four projects from those available below and, if invited for interview, must contact prospective supervisors ahead of interview.
- Submission deadline: Midday, Monday 11 January 2027
- Shortlisting: By Friday 12 February 2027
- Online interviews: Online, week beginning 1 March 2027
For further information on the programme or application process, please email WOH@surrey.ac.uk.
For further information on individual projects, please contact the supervisors directly. Their email addresses can be found within the project listings below.
Apply now
For more information view: Q&As from the Wessex One Health Doctoral Programme Webinar (PDF).
Projects
University of Surrey
Theme(s): Understanding Disease Spread
Lead partner: University of Surrey
Supervisor: Roberto La Ragione, r.laragione@surrey.ac.uk
Joint partner: UKHSA
Supervisor: Marie Chattaway, marie.chattaway@ukhsa.gov.uk
Project Summary
Domestic pets are an integral part of many households and provide substantial social and health benefits. However, pets and feed, can also act as reservoirs of antimicrobial resistance and zoonotic pathogens including Salmonella, posing potential risks to human health. While foodborne transmission remains the principal route of human salmonellosis, the contribution of companion animals to the transmission and persistence of Salmonella is poorly understood. Addressing this knowledge gap is essential to inform risk mitigation strategies within a One Health framework.
This PhD project will investigate the One Health population analyses, potential transmission and public health significance of Salmonella associated with pets in the UK. The project will combine comparative genomics, host and surveillance data analyses to characterise Salmonella isolates from peta and humans. Using historical and contemporary isolate collections held by the Animal and Plant Health Agency (APHA) and the UK Health Security Agency (UKHSA), the student will assess the genetic relatedness of isolates recovered from pets, feed and people, investigate potential links and shared Salmonella lineages across human, companion animal and other relevant one health sources , and evaluating the distribution of virulence and antimicrobial resistance determinants across host populations.
The project will also explore the phenotypic factors associated with successful joint lineage and persistence by using fitness models (Biolog, tissue culture, and biofilms assays). These analyses will provide insights into the characteristics that enable certain Salmonella lineages to adapt to and circulate between animal and human hosts.
The student will benefit from an interdisciplinary training environment spanning three leading institutions: the University of Surrey (Guildford), APHA (Weybridge, additional supervisor Francesca Martelli) and UKHSA (Colindale). This partnership will equip the student to generate evidence on how zoonotic Salmonella and antimicrobial resistance spreads across pets, pet food and people, supporting One Health surveillance, prevention and control in the UK.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Understanding Disease Spread
Lead partner: University of Surrey
Supervisor: Gianni Lo Iacono, g.loiacono@surrey.ac.uk
Joint partner: APHA
Supervisor: Nicholas Johnson, nick.johnson@apha.gov.uk
Project Summary
Mosquitoes are among the deadliest animals, transmitting diseases that affect people and animals. West Nile virus (WNV) is the most widespread zoonotic arbovirus in Europe, maintained in an enzootic cycle between Culex mosquitoes and birds, with humans and horses as incidental hosts. Climate and land-use change are altering mosquito activity and bird communities and may reshape when and where WNV risk is highest.
This project focuses on the combined effects of weather, climate and bird biodiversity, and how these change by season in driving WNV transmission. We have multi-year surveillance data from Italy, where many bird species are tested for WNV alongside mosquito monitoring. Although sampling is opportunistic rather than fully systematic, these data provide a basis to identify which bird species are infected, when and where, and to calibrate and validate transmission models.
You will integrate WNV detection data collected/curated by Italian collaborators in birds and mosquitoes with environmental datasets (weather, land-use and climate projections) and external indicators of bird abundance such as the Farmland Bird Index, which allow comparison of abundance of key species between seasons. Building on our previous work modelling Rift Valley fever, you will develop eco-epidemiological mechanistic models to quantify how recent weather, seasonal bird community structure and prior infections jointly determine the probability of detecting WNV and the risk of spillover to humans and animals.
Once validated on Italian data, the models will be adapted to the UK, using surveillance data from APHA and current/projected climate and bird community scenarios to:
- Identify key seasons and locations for WNV emergence
- Highlight bird species that are most important as reservoirs at different times of year.
This interdisciplinary project suits students interested in infectious diseases, One Health, data science or modelling.
Additional supervisors include Martha Betson (Surrey), Marion England (Pirbright) and Mattia Calzolari (IZS, Italy).
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Detection, Prevention and Intervention; Infection and Cellular Biology
Lead partner: University of Surrey
Supervisor: Dr Qibo Zhang, qibo.zhang@surrey.ac.uk
Joint partner: UKHSA
Supervisor: Dr Julia Tree, Julia.Tree@ukhsa.gov.uk
Project Summary
Rationale: Immunity against virus infection critically depend on T cell and antibody responses produced in immune system. Development of immunomodulatory agents/drugs to enhance these immune responses is an important strategy for better efficacy of treatment such as antibody-based or anti-viral therapy. Testing of new drugs typically involves animal models to generate pre-clinical data. There is a growing momentum to replace/reduce animal experimentation. The availability of complex in vitro models such as human organoid system may provide experimental data that better predict clinical outcomes in humans. This PhD project will evaluate the effectiveness of new immunomodulatory agents and antiviral drugs in anti-viral immunity using human immune organoids.
Approaches: Using an in vitro immune organoid system established in Dr Zhang’s lab, based on human immune tissue/cells and shown being able to study immune responses to microbial infection and vaccines, this project will characterise/evaluate the effectiveness of immunomodulatory agents/ antivirals on anti-viral immunity against key pathogens. T cell- and antibody-mediated immunity to influenza A, SARS-CoV-2, MERS-CoV, Herpes simplex virus(HSV) will be analysed. CD4/CD8 T cell responses, cytokine profiles, and antibody responses induced by the virus antigens, with/without immunomodulatory agents (e.g. TLR4, TLR7/8 agonists, interferons) will be evaluated, using state-of-the-art techniques including confocal microscopy, flowcytometry, immunoassays and virus neutralisation analysis (within BSL-3 facilities).
The PhD student will be jointly supervised by multidisciplinary teams at UoS(Dr Zhang, Prof Elliot), UKHSA(Drs Tree and Horton), with expertise/experience in immunology, anti-viral drug testing and infection biology.
Impact: An in vitro immune organoid system with capacities testing immunotherapeutic anti-viral agents and better predicting clinical outcomes will speed up development of effective anti-viral drugs for humans and improve pandemic preparedness against new virus infection.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Detection, Prevention and Intervention; Infection and Cellular Biology
Lead partner: University of Surrey
Supervisor: Salvatore Santamaria, s.santamaria@surrey.ac.uk
Joint partner: UKHSA
Supervisor: Anika Singanayagam, Anika.Singanayagam@ukhsa.gov.uk
Project Summary
Upper respiratory tract infections are the leading cause of acute disease worldwide with over 12 billion incidents a year. Respiratory viruses including influenza and respiratory syncytial virus (RSV) circulate seasonally and are associated with significant morbidity and mortality. Current prevention (vaccines) and intervention strategies (antivirals) are focused exclusively on the virus but are only moderately effective. An area that has been largely ignored in the quest for new treatments is the impact of host responses on disease severity and eventual outcome. Extracellular matrix (ECM)-associated metalloproteinases called ADAMTSs were recently discovered to contribute to virus immunity and disease outcomes. However, the mechanisms behind these phenotypes are not elucidated.
We hypothesise that pharmacologic inhibition of ADAMTS4 may improve survival after lung viral infection, while increasing ADAMTS5 levels may improve survival. By using selective anti-ADAMTS4 and ADAMTS5 monoclonal antibodies (mAbs), proteomics, degradomics, and transcriptomics, we will assess the contribution of these proteases to viral lung infections in cell-based systems. Specifically, we will: 1) assess the effect of anti-ADAMTS mAbs on primary and derived cell lines infected with RSV and influenza virus; 2) characterise the transcriptional response to viral infection; 3) uncover changes in the ECM using bottom-up proteomics; 4) characterise the lung-specific ADAMTS4/5 substrate repertoire (i.e., their degradome).
These studies will not only elucidate the role of ECM degradation in the host response to viral infections, but may also establish ADAMTS proteases as pharmacological targets. In particular, anti-ADAMTS mAbs may represent one-size-fits-all drugs not needing seasonal formulation and optimisation that can be deployed and administered to at-risk groups (for example the elderly and the immunocompromised) to prevent severe outcomes. Overall, this will reduce the burden of disease and socioeconomic impact associated with viral lung infections and improve pandemic preparedness.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Understanding Disease Spread; Infection and Cellular Biology
Lead partner: University of Surrey
Supervisor: Jai Mehat, jw.mehat@surrey.ac.uk
Joint partner: The Pirbright Institute
Supervisor: Wilhelm Gerner, Wilhelm.Gerner@pirbright.ac.uk
Project Summary
The University of Surrey, in collaboration with The Pirbright Institute, are offering an exciting PhD opportunity to investigate the complex interplay between viral and bacterial pathogens and host biology that contribute to bovine respiratory disease.
Project background: Bovine Respiratory Disease is the most costly health challenge in global cattle production. It is fundamentally a multifactorial disease, where host biology, pathogens, and production-system stressors collide.
This project aims to explore the cooperative dynamics by which bovine respiratory syncytial virus (BRSV) enhances infection by high-risk genetic lineages of the bacterial pathogens Pasteurella multocida and Mannheimia haemolytica, and uncover how this pathogen-host network drives the most severe forms of BRD.
Approaches: The successful candidate will apply cutting-edge bovine respiratory organoid and Air-Liquid Interface models, alongside advanced microscopy and infection-biology approaches, to investigate the synergistic mechanisms that drive co-infection between BRSV, P. multocida, and M. haemolytica.
The student will examine how maturation of the bovine epithelia shapes viral infection, epithelial integrity and host-cell pathways, and how these changes promote bacterial attachment, infiltration, and maintenance, while also uncovering bacterial metabolic traits that enhance co-infection.
By dissecting how BRSV-driven epithelial damage and developmental stage converge to modulate co-infection with P. multocida and M. haemolytica, this work will generate fundamental insight into bovine respiratory disease co-infection dynamics and help identify which pathogen genotype combinations pose the greatest risk to cattle health, productivity and food security.
Impact and Career Opportunities: This PhD opportunity offers the unique benefit of collaboration between the University of Surrey and The Pirbright Institute. You will join a multidisciplinary research team encompassing groups specialising in bacteriology, virology, vaccinology, and One Health. This project will prepare you for careers across academia, animal-health research, biotechnology, vaccines, diagnostics and the wider livestock sector, while developing specialist technical skills alongside experience in collaborative research, and translational science.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Infection and Cellular Biology; Detection, Prevention and Intervention
Lead partner: University of Surrey
Supervisor: Ayman Ibrahim, a.m.ibrahim@surrey.ac.uk
Joint partner: UKHSA
Supervisor: Javier Salguero, Javier.Salguero@ukhsa.gov.uk
Project Summary
Antimicrobial resistance (AMR) is a major global One Health challenge requiring coordinated action across human health, veterinary medicine and the wider environment. Fluoroquinolones are broad-spectrum antimicrobials that have played an important role in the treatment of bacterial infections in both human and veterinary medicine. However, increasing antimicrobial resistance, together with concerns regarding adverse effects, has resulted in greater emphasis on responsible and evidence-based use of this important drug class.
Effective antimicrobial stewardship is not determined solely by whether an antibiotic can control infection. Treatment decisions must also consider differences in toxicity, patient susceptibility and the potential consequences of replacing or restricting individual antimicrobial agents. A better understanding of these factors could help optimise the use of existing antibiotics while antimicrobial options are becoming increasingly constrained by resistance.
This PhD project will investigate fluoroquinolones as a model antimicrobial class in which efficacy, stewardship and drug safety intersect. The project will focus on cardiovascular toxicity, an important but incompletely understood adverse effect associated with some fluoroquinolones. Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) will provide a physiologically relevant platform for comparing the effects of different fluoroquinolones and determining the mechanisms underlying susceptibility to drug-induced electrical disturbances.
The student will establish concentration-response profiles for selected fluoroquinolones and investigate their effects on cardiac electrophysiology, calcium handling, contractility and cellular stress. Particular attention will be given to whether individual members of the fluoroquinolone class produce distinct safety profiles and how clinically relevant factors, including drug combinations and underlying cellular susceptibility, modify these responses.
By integrating antimicrobial stewardship with mechanistic toxicology, the project will generate evidence that could contribute to safer and more informed antimicrobial use rather than simply antimicrobial restriction. The work therefore sits at the interface of AMR, drug safety, human health and veterinary medicine and provides a strong One Health training environment.
Aims
Aim 1 – Define the wider One Health context of fluoroquinolone use.
Evaluate the use and importance of selected fluoroquinolones across human and veterinary medicine, considering antimicrobial resistance, stewardship priorities and existing safety concerns.
Aim 2 – Compare the safety profiles of clinically relevant fluoroquinolones.
Use human iPSC-derived cardiomyocytes to establish concentration-dependent effects of selected agents on cellular electrophysiology, calcium handling and cardiac function.
Aim 3 – Identify mechanisms and factors contributing to antimicrobial-associated cardiotoxicity.
Determine the cellular pathways responsible for adverse responses and investigate how drug combinations, exposure and underlying cardiac susceptibility influence toxicity.
Aim 4 – Support evidence-based antimicrobial stewardship.
Integrate experimental findings with the One Health context of fluoroquinolone use to identify how improved understanding of drug-specific safety could contribute to more informed antimicrobial selection and stewardship.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Microbial Evolution and Drug Resistance; Understanding Disease Spread
Lead partner: University of Surrey
Supervisor: Martha Betson, m.betson@surrey.ac.uk
Joint partner: APHA
Supervisor: Ben Jones, Ben.Jones@apha.gov.uk
Project Summary
The gamebird industry contributes significantly to the rural economy in the UK and plays an important role in habitat conservation. Each year, tens of millions of gamebirds are reared on rearing sites within specifically conserved habitats and then released into the environment. Despite continuing improvements in husbandry practices, bacterial, viral, fungal and parasitic infections remain common in gamebirds during the rearing season, leading to disease and mortality, managed mainly with antimicrobials. Gamebirds are often infested with ticks and there is mounting evidence that gamebirds play a role in maintaining local tick populations, potentially increasing the risk of tick-borne zoonotic disease transmission and spread of antimicrobial resistance (AMR).
This project builds on ongoing work at the University of Surrey in collaboration with gamebird vets, bringing in expertise in ticks and tick-borne diseases at the APHA. The overall project aim is to determine whether gamebird rearing and release increases the risk of tick-borne disease transmission and tick-mediated spread of antimicrobial resistance (AMR).
This will be achieved through:
- Sampling ticks from the environment at rearing/release and control sites and processing gamebird samples provided by vets, gamekeepers and shoots.
- Analysing caecal and faecal microbiomes of gamebirds and the ticks which infest them, as well as of ticks collected from the environment.
- Investigating the prevalence of tick-borne zoonotic infections (e.g. Borrelia burgdorferi) and different microbial populations in gamebirds using microbiome data and targeted PCR and LAMP assays.
- Characterising and comparing antimicrobial resistance genes in gamebirds and ticks collected from gamebirds and different environments.
The student will gain training experience in field sampling, lab-based parasitology, microbiology and molecular techniques, and bioinformatics analysis.
The potential project impact is an improved understanding of the role of gamebirds and ticks in spread of zoonotic infections and AMR to guide evidenced-based strategies to mitigate transmission risk.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Infection and Cellular Biology
Lead partner: University of Surrey
Supervisor: Dr Lisa Holbrook, l.holbrook@surrey.ac.uk
Joint partner: UKHSA
Supervisor: Dr Stuart Dowall, Stuart.Dowall@ukhsa.gov.uk
Project Summary
Rift Valley fever virus (RVFV) is a mosquito-transmitted, zoonotic, emerging phlebovirus categorised by the World Health Organisation (WHO) as a high-consequence, priority pathogen due to its geographical expansion and lack of effective treatments. It can cause viral haemorrhagic fever in humans and livestock characterised by necrotic lesions in major organs, decreased circulation of platelets, coagulation defects and increased vascular permeability resulting in oedema, hypotension, shock, and in severe cases, death. How RVFV induces pathology remains largely unknown and understanding the molecular mechanisms underlying RVFV infection and pathology will identify new avenues for therapeutic development.
Haemorrhagic fever-inducing viruses, including RVFV, cause platelet destruction or dysfunction. Platelets are essential in haemostasis, vascular integrity, in immunity, and they can be activated aberrantly by interaction with viruses or virus-infected cells, causing adherence to the vascular endothelium. We hypothesise that RVFV-activated platelets adhere to endothelial cells, increasing vascular permeability and reducing the circulating platelet number leading to haemorrhage. Treatments that prevent or correct RVFV-induced platelet loss and dysfunction have the potential to ameliorate platelet-mediated pathology and to significantly improve clinical outcome.
Supervised by Dr Lisa Holbrook (University of Surrey), Dr Stuart Dowall (UKHSA) and Dr Karen Mansfield (APHA), this project will examine the molecular and immune interactions between RVFV, platelets and the endothelium and explore the mechanisms by which these may contribute to RVFV-induced pathology using a combination of in vitro and ex vivo methods. Final confirmation of in vitro mechanisms will be evaluated using material from RVFV challenge animal models allowing direct comparison with disease severity and clinical outcome.
This 4-year interdisciplinary project will provide training in platelet biology alongside high containment virology, ex vivo models, molecular and cellular biology. The student will primarily be based at the University of Surrey but will also spend time in the laboratories at UKHSA and APHA.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Infection and Cellular Biology; Detection, Prevention and Intervention
Lead partner: University of Surrey
Supervisor: Dr Matthew Siggins, m.siggins@surrey.ac.uk
Joint partner: APHA
Supervisor: Professor Falko Steinbach, falko.steinbach@apha.gov.uk
Project Summary
Infectious diseases and antimicrobial resistance are major global One Health challenges. Better vaccines are urgently needed to prevent disease and reduce antibiotic use, but veterinary vaccine development is limited by gaps in our understanding of species-specific immunity and reliance on costly animal studies.
Recent advances in human immune organoids show that 3D models of tonsils and lymph nodes can generate antigen-specific T-cell, B-cell and antibody responses. Studies also suggest that using stromal “scaffolding” cells can support tissue organisation and enhance antibody responses. Comparable livestock models remain less established, particularly for assessing vaccine-induced immunity.
Working within advanced, specialist facilities across the University of Surrey and the Animal and Plant Health Agency (APHA), the student will progress through three phases: first, defining responses to viral and bacterial vaccine antigens in vaccinated animals and living lymphoid tissues; next, engineering 3D tonsil and lymph-node organoids with and without stromal support; and finally, testing how the organoids respond to vaccine antigens and whether these responses reflect those observed in vivo.
You will be supervised by Dr Matthew Siggins, Dr Qibo Zhang and Professor Falko Steinbach (APHA), receiving interdisciplinary training in immunology, organoid engineering and vaccinology. Methods will include confocal microscopy, high-parameter spectral flow cytometry and AI-driven image analysis. You will also have opportunities to collaborate with researchers across Surrey and APHA, present your work, and develop wider professional skills.
Ultimately, this project could advance our understanding of immunity and help identify promising vaccine candidates with fewer animal studies. The work could support the development of better veterinary vaccines and inform future human vaccine research.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Understanding Disease Spread; Microbial Evolution and Drug Resistance
Lead partner: University of Surrey
Supervisor: Gill Elliott, g.elliott@surrey.ac.uk
Joint partner: UKHSA
Supervisor: Steve Pullan, Steven.Pullan@UKHSA.gov.uk
Project Summary
Herpes simplex virus is an important human pathogen with over 4 billion infected worldwide. It infects the epidermis or mucosae, before establishing lifelong latent infection in sensory neurons, reactivating periodically to cause cold sores or genital herpes. Serious consequences associated with HSV infection include infectious blindness, encephalitis resulting in death or devastating brain damage, and the transmission of HIV, while in developing countries neonatal herpes remains a cause of death in newborns.
HSV1 is a large DNA virus with a stable 152 kb genome; genetic differences are in the range of 2 to 4%. HSV1 transmits between cells through two routes – direct cell-to-cell spread and extracellular release - and despite the limited genetic variation, there are striking differences in the efficiency of extracellular release with some strains releasing > 1,000-fold less virus than others, while replicating with the same efficiency. Nonetheless, the molecular explanation for restricted virus release is not yet known.
In this interdisciplinary project you will study a library of ~ 50 HSV1 clinical isolates and will collect new isolates from patients with cold sores. At the University of Surrey you will apply high-throughput virological techniques to establish the phenotypes of these viruses and investigate how release is restricted at the cellular level.
In parallel, at UKHSA you will sequence these virus genomes both directly from clinical samples and following virus isolation in cell culture, enabling comparison of cultured and uncultured virus populations while also characterising co-detected viruses and bacterial communities present within samples, and will develop a bespoke bioinformatic pipeline to perform de novo genome assembly.
CRISPR-Cas9 editing will be used to insert putative release-restricting variations into an actively releasing strain to switch the phenotype. In this way, you will correlate subtle genetic variations with release phenotype and establish the molecular fingerprint for HSV1 extracellular release.
Apply now
Please apply by submitting an application form and completing our EDI survey.
University of Exeter
Theme(s): Infection and Cellular Biology
Lead partner: University of Exeter
Supervisor: Gordon Brown, gordon.brown@exeter.ac.uk
Joint partner: UKHSA
Supervisor: Javier Salguero, Javier.Salguero@ukhsa.gov.uk
Project Summary
Bovine tuberculosis, caused by Mycobacterium bovis, is an important animal health and economic problem for the UK cattle industry. Recent research showed that mycobacterial α-glucans bind Dectin-1 in mouse and human macrophages. This interaction changes how macrophages process internalised mycobacteria and promotes bacterial survival (Torigoe et al., Science Immunology, 2026; PMID: 41512079).
This PhD project will investigate the structure and function of bovine Dectin-1 and determine its role during mycobacterial infection. Structural modelling will be used to predict how bovine Dectin-1 recognises mycobacterial α-glucans and identify key amino acids that may control ligand binding or receptor signalling. Selected residues will be altered using site-directed mutagenesis to test their importance experimentally.
Normal and mutated forms of bovine Dectin-1 will be introduced into laboratory cell lines that do not naturally express the receptor. These transfected cells will provide a controlled system for measuring receptor expression, α-glucan binding, recognition of whole mycobacteria, and cellular uptake. Flow cytometry, microscopy, reporter assays, and cytokine measurements will assess Dectin-1-dependent responses. Comparing normal and mutated receptors will reveal which structural features are required for mycobacterial recognition and signalling.
Macrophage cell lines expressing bovine Dectin-1 will be infected mainly with M. bovis BCG and M. smegmatis, allowing most experiments to be performed in BSL-2 laboratories. The project will measure intracellular bacterial survival and killing, phagosome maturation, and autophagy. Recruitment of LC3, p62, and lysosomal markers will be examined alongside activation of key signalling pathways, including mTOR. Blocking antibodies and pathway inhibitors will establish which effects depend specifically on Dectin-1.The main findings will then be confirmed in primary bovine monocyte-derived macrophages using pathogenic mycobacteria. This collaboration between the University of Exeter, UKHSA, and the Royal Veterinary College will improve understanding of bovine immunity, identify possible host-directed approaches for controlling bovine tuberculosis, and support future disease control strategies.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Microbial Evolution and Drug Resistance
Lead partner: University of Exeter
Supervisor: Jane Usher, j.usher@exeter.ac.uk
Joint partner: UKHSA
Supervisor: Charlotte Hind, Charlotte.Hind@ukhsa.gov.uk
Project Summary
Antifungal resistance is a growing threat to human health, yet the limited number of antifungal drug classes leaves clinicians with few options when resistance emerges. This project will identify genetic vulnerabilities in drug-resistant fungal pathogens and translate them into opportunities for combination therapy and drug discovery.
The central hypothesis is that resistance-conferring mutations create new dependencies that can be exposed through systematic genetic interaction screening. Using a clinically relevant Candida species as the primary model, the student will construct strains carrying defined resistance mutations and perform genome-wide synthetic-lethality and drug-sensitisation screens. Quantitative interaction maps will identify genes and pathways that are dispensable in susceptible cells but essential in resistant backgrounds or during antifungal exposure. Priority interactions will be validated using targeted gene disruption, competition assays, and phenotypic testing under infection-relevant conditions.
The drug-discovery component will be delivered in partnership with a placement the UK Health Security Agency (UKHSA) through their Open Innovation in AMR platform. Genetic hits will be matched to tractable proteins and pathways, then used to guide screening of compounds available through UKHSA. High-throughput assays will identify molecules that selectively inhibit resistant strains or restore activity of existing antifungals. Confirmed hits will undergo dose-response, checker board synergy, cytotoxicity and preliminary mechanism-of-action studies. The most promising genetic and chemical combinations will be evaluated in infection models to establish efficacy and prioritise candidates for further development.
This project integrates functional genomics, bioinformatics, molecular mycology and translational pharmacology. It will provide the student with interdisciplinary training in robotic screening, genetic network analysis, compound screening and antimicrobial development, alongside experience of working across academic and public-health environments. By connecting unbiased genetic discovery directly to UKHSA-supported chemical screening, the work will reveal new therapeutic targets, generate candidate antifungal combinations and establish a transferable pipeline for tackling antimicrobial resistance in fungal pathogens.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Infection and Cellular Biology; Microbial Evolution and Drug Resistance
Lead partner: University of Exeter
Supervisor: Elizabeth Ballou, e.ballou@exeter.ac.uk
Joint partner: Dstl
Supervisor: Sarah Harding, SVHARDING@mail.dstl.gov.uk
Project Summary
Deep soft tissue infections arrise from a challenging combination of environmental and commensal microbes and can impact patients recovering from surgery, as well as trauma and combat wounds. For deep soft tissue wounds, we have poor understanding of how the bacteria and fungi that colonise, invade, and cause traumatic damage interact with each other, with antibiotics, and with the host. Treatment generally requires surgery or even amputation to remove infected tissue. We urgently need a better understanding of how to identify, treat, and enhance wound healing for these complex infections.
A major hurdle to understanding polymicrobial wounds is a lack of real-world relevant models. In this project, the student will work with experts in bacterial and fungal infection biology to develop a model that recapitulates wound complexity in a tuneable way, allowing a holistic understanding of wound pathophysiology and infection progression, and also enabling therapeutic testing. The student will build on and expand existing protocols to develop improved understanding of how Gram-positive, Gram-negative and invasive fungal species interact both on wounded ex-vivo human skin and using organoid and microfluidic in vitro models.
The student will work with researchers in the University of Exeter's MRC Centre for Medical Mycology (Elizabeth Ballou, Bill Horsnel, Dora Corzo Leon), Living Systems Institute (Stefano Pagliara) and the Defence Science and Technology Laboratory. There will be an emphasis on developing skills in robust assay development; advanced bioimaging including tissue clarification, microfluidic imaging, and the use of AI for 3D and 4D image analysis; and analysis of how therapeutics influence polymicrobial interactions. This will aid understanding of how to rapidly and accurately treat traumatic wounds in both civilian and military populations to limit pathophysiology and the emergence of multi-drug resistant infections.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Microbial Evolution and Drug Resistance
Lead partner: University of Exeter
Supervisor: Rhys Farrer, r.farrer@exeter.ac.uk
Joint partner: UKHSA
Supervisor: Andy Borman, Andrew.borman@ukhsa.gov.uk
Project Summary
Antifungal resistance is an increasing global health threat, limiting our ability to treat life-threatening fungal infections. Candida auris is an emerging fungal pathogen of particular concern due to its ability to spread within healthcare settings, persist in the environment, and develop resistance to multiple classes of antifungal drugs. Since its discovery in 2009, C. auris has emerged independently across several continents, with six genetically distinct lineages now recognised. Understanding how antifungal resistance arises and evolves within these populations is essential for improving treatment strategies and anticipating future resistance.
This PhD project will investigate the evolutionary processes driving antifungal resistance in C. auris by combining population genomics with laboratory-based experimental evolution. First, we will analyse whole-genome sequencing data from global C. auris populations to identify genetic variation, signatures of natural selection, and differences in resistance-associated genes across the six lineages. Particular attention will be given to ERG11 and FKS1, which are associated with resistance to azoles and echinocandins, respectively. Population genetic approaches, including measures of genetic differentiation, selection analyses, and Bayesian modelling, will help identify evolutionary patterns and potential resistance-associated mutations.
Second, laboratory evolution experiments will expose C. auris populations to antifungal drugs over successive generations, allowing us to observe how resistance develops in real time. Whole-genome sequencing of evolved populations will reveal emerging mutations and help determine whether different lineages follow similar or distinct evolutionary pathways.
By integrating genomic and experimental approaches, this project will improve our understanding of how antifungal resistance emerges, spreads, and potentially becomes predictable. The findings could inform antifungal surveillance, resistance diagnostics, and future treatment strategies, contributing to efforts to combat antimicrobial resistance within a One Health framework.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Detection, Prevention and Intervention; Understanding Disease Spread
Lead partner: University of Exeter
Supervisor: Ivana Gudelj, i.gudelj@exeter.ac.uk
Joint partner: Dstl
Supervisor: Richard Thomas, RJTHOMAS@mail.dstl.gov.uk
Project Summary
Every day, we breathe in fungal spores released from soil, vegetation and other surfaces. While most people remain unaffected, exposure to Aspergillus fumigatus, a common environmental mould, can cause life-threatening infections in vulnerable patients. Invasive aspergillosis is associated with mortality rates of up to 50% in immunocompromised individuals, making A. fumigatus one of the world's most important fungal pathogens. Understanding how people become exposed to this fungus is therefore an important challenge in medical mycology.
But what causes these deadly spores to become airborne, and how does weather influence our exposure? Despite the importance of airborne transmission, we still know remarkably little about how spores are released into the air. Wind, rainfall and humidity can all influence this process, known as particle resuspension, yet their effects remain difficult to quantify under realistic environmental conditions. Understanding these mechanisms is essential for predicting human exposure and developing effective strategies to reduce infection risks.
The proposed PhD project will tackle this challenge using the University of Exeter's Global Meteorological Simulator (GMS), a unique, BBSRC-funded facility that recreates realistic weather conditions in the laboratory. The student will investigate how A. fumigatus spores become airborne from different surfaces and how changing weather conditions influence their liberation and dispersal. Combining microbiological experiments, high-speed imaging and quantitative analysis, they will investigate how weather and surface properties interact to control spore release.
The project includes collaboration with the Defence Science and Technology Laboratory (DSTL), whose researchers develop mathematical models of particle resuspension. Experimental measurements from the GMS will help test and improve these models, linking laboratory discoveries to predictions of airborne fungal exposure.
Working with supervisors specialising in medical mycology, environmental microbiology and quantitative modelling, the student will gain interdisciplinary research skills while investigating a fundamental question with implications for reducing exposure to a major human fungal pathogen.
Additional Supervisory Support: Professor Adilia Warris, University of Exeter.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Infection and Cellular Biology
Lead partner: University of Exeter
Supervisor: Dr Liliane Mukaremera, L.Mukaremera@exeter.ac.uk
Joint partner: UKHSA
Supervisor: Dr Chang Guo, Chang.Guo@ukhsa.gov.uk
Project Summary
How does tuberculosis reshape the immune response to Cryptococcus, and how does the fungus adapt in return? This PhD will investigate this interplay using human induced pluripotent stem cell (iPSC)-derived macrophages and microglia-like cells, modelling immune interactions at two critical sites of cryptococcal infection: the lung and brain.
Our preliminary findings suggest that mycobacterial exposure alters Cryptococcus morphology, capsule size and cell-wall composition. These changes could influence fungal recognition and survival, yet how they develop within human immune cells and contribute to impaired infection control remains unclear.
We hypothesise that Mycobacterium tuberculosis (MTb) alters macrophage and microglial function, creating conditions that favour cryptococcal adaptation and persistence. Three connected work packages will test this hypothesis:
- Define how co-infection shapes immune control. Using iPSC-derived immune cells, you will compare single-infection and co-infection conditions to determine how MTb influences pathogen recognition, phagocytosis, inflammatory responses and intracellular fungal survival employing cutting-edge technologies e.g. imaging spectral flow cytometry.
- Reveal fungal adaptation within the host-cell environment. Alongside immune measurements, you will track ultrastructural alterations in cryptococcal morphology, capsule and cell-wall architecture across clinical isolates. Advanced multi-modal imaging microscopy will connect fungal adaptations with host-cell responses and infection outcomes.
- Establish how host responses and fungal adaptation influence each other. Guided by the preceding findings, you will test by RNA-seq selected host pathways and fungal phenotypes to distinguish changes that promote persistence from those associated with effective immune control.
By measuring host and pathogen responses together, this programme will reveal how co-infection reshapes the balance between fungal containment and survival in distinct human immune-cell environments. You will gain interdisciplinary training in stem cell-derived infection models, fungal and mycobacterial biology, immunology and advanced imaging, while identifying mechanisms that could inform future approaches to managing complex infections.
Additional PI involved:
Dr. Ivy Dambuza: https://pure.qub.ac.uk/en/persons/ivy-dambuza/
Apply now
Please apply by submitting an application form and completing our EDI survey.
University of Sussex
Theme(s): Infection and Cellular Biology
Lead partner: University of Sussex
Supervisor: Ben Towler, b.towler@sussex.ac.uk
Joint partner: The Pirbright Institute
Supervisor: Nicolas Locker, Nicolas.Locker@pirbright.ac.uk
Project Summary
Foot-and-mouth disease virus (FMDV) is a highly contagious pathogen. Outbreaks can have devastating economic consequences, resulting in animal movement restrictions, trade disruption and large-scale control measures. Surprisingly, how the virus reshapes host post-transcriptional responses to support replication remains unresolved.
RNA binding proteins (RBPs) are critical regulators of gene expression, influencing RNA processing, localisation, translation and decay, and are often directly targeted by viral factors to support replication. Our recent work has explored how cellular stressors reshape RBP activity and identified G3BP1 as an antiviral factor, independent of its role in RNA condensation. Importantly, G3BP1 plays multifaceted roles in cellular processes, regulating RNA metabolism and Interferon signalling through multiple pathways including RIG-I and cGAS-STING.
This project will build upon previous work to investigate RBP activity during FMDV infection, focusing on how they control viral replication and co-ordinate host antiviral responses. We hypothesise that FMDV infection alters host RBP activity, beyond just G3BP1, with both virus-driven and host-mediated processes collectively shaping cellular stress responses and the outcome of infection.
This project aims to:
1. Identify how FMDV remodels the host RBP landscape and how RBPs contribute to the outcome of infection.
2. Establish how G3BP1 and other RBPs regulate antiviral signalling and viral replication.
3. Determine how RBP-mediated regulation affects the stability and translation of stress-sensitive transcripts.
By integrating targeted screens, transcriptomic, proteomic and functional approaches, the project will uncover new relationships between RBPs, cellular stress and FMDV infection. The research will provide fundamental insights into host–virus interactions, conserved antiviral responses, and may identify pathways to inform future approaches to FMDV control.
The student will receive interdisciplinary training in virology, RNA biology, cellular biology, omics and bioinformatics, drawing on the expertise of the supervisory team across the Sussex RNA Research Centre and Pirbright Institute with opportunities to work across both sites.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Detection, Prevention and Intervention
Lead partner: University of Sussex
Supervisor: Erika Mancini, erika.mancini@sussex.ac.uk
Joint partner: UKHSA
Supervisor: Charlotte Hind, Charlotte.Hind@ukhsa.gov.uk
Project Summary
Multi-drug resistant fungal infections are an escalating global health threat, causing an estimated 6.5 million severe infections each year. Current antifungal medications are rapidly losing efficacy as resistance spreads, creating an urgent need for therapies with novel mechanisms of action. Pathogenic fungi rely on alternative oxidase (AOX), a mitochondrial enzyme upregulated during metabolic stress, to survive standard treatments. Because AOX is absent from the mammalian respiratory chain, it represents an ideal target for selective drug design. However, rational drug development remains constrained by the lack of fungal AOX structures.
This interdisciplinary project unites protein structural biology, computational drug discovery, and translational pharmacology. Based at the Sussex Drug Discovery Centre, you will be fully integrated into a multidisciplinary environment with access to state-of-the-art facilities, co-supervised by a Medicinal Chemistry expert, Prof John Spencer and mentored from members of the university spin-off Alternox, who bring world-leading expertise in AOX biology. You will express, purify, and solve the first high-resolution 3D structures of fungal AOX using X-ray crystallography and cryo-EM. Using these atomic coordinates, you will conduct virtual screening and structure-based drug design to build libraries of novel inhibitory scaffolds. You will then evaluate direct target engagement using biophysical assays and validate the efficacy of lead compounds in fungal pathogen models to suppress respiration and overcome drug resistance.
Solving the atomic architecture of fungal AOX will resolve a longstanding bottleneck in the field and accelerate the discovery of first-in-class antifungal therapeutics. This research directly addresses the crisis of antimicrobial resistance by delivering validated chemical matter against a clinically vital target. As a doctoral researcher, you will gain comprehensive, industry-relevant training bridging structural biophysics, computational chemistry, and infection biology, equipping you for leadership roles across academic research and the biotechnology sector.
Apply now
Please apply by submitting an application form and completing our EDI Survey.
Theme(s): Understanding Disease Spread; Microbial Evolution and Drug Resistance
Lead partner: University of Sussex
Supervisor: William Hughes, william.hughes@sussex.ac.uk
Joint partner: APHA
Supervisor: Arran Folly, arran.folly@apha.gov.uk
Project Summary
Honeybees and other pollinators are of tremendous economic importance, providing essential pollination services to agriculture, but they are increasingly threatened by a diversity of pathogens and other stressors. There is growing recognition of the need for a better understanding of the complex interactions between the host, pathogens and stressors for the sustainable provision of pollination services. Chronic Bee Paralysis Virus (CBPV) is a relatively neglected disease that is both an important problem for UK bees and an intriguing pathogen from a virology perspective, but it is still poorly understood, which greatly hinders the development of appropriate management strategies.
This exciting project will address this knowledge gap by investigating the host-pathogen dynamics of CBPV in honeybees at within-host, colony and population levels in a cross-agency collaboration between the University of Sussex (Prof William Hughes), APHA (Dr Arran Folly), National Bee Unit (Nigel Semmence) and Pirbright Institute (Dr Kevin Maringer). The work will involve quantifying virus replication and interactions with the host immune response, controlled virus inoculation experiments to examine host-pathogen transmission dynamics, and integrating field sampling and syndromic surveillance into spatial and phylogenetic analyses to investigate virus patterns and persistence across the UK. The results will both advance our fundamental understanding of host-virus dynamics and be of applied impact in informing the management of an important, neglected disease.
The student will receive a diversity of interdisciplinary training, including two professional internships at APHA and the Pirbright Institute, encompassing cutting-edge virology, laboratory experiments, and advanced statistical analyses, as well as first-hand experience of applied stakeholder knowledge exchange with the National Bee Unit. The project will provide the student with an outstanding range of skills and experience to support a subsequent career across a broad diversity of fields in academia and industry, health and veterinary sciences, agriculture and conservation.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Understanding Disease Spread
Lead partner: University of Sussex
Supervisor: Beth Nicholls, e.nicholls@sussex.ac.uk
Joint partner: The Pirbright Institute
Supervisor: Kevin Maringer, Kevin.Maringer@pirbright.ac.uk
Project Summary
Bumblebees are ecologically and economically important pollinators that are commercially bred to pollinate food crops. Maintaining healthy, resilient populations is therefore important for both agriculture and pollinator health. However, bumblebees face interacting challenges from pathogens, poor nutrition and extreme temperatures, and we know little about how these factors combine to determine infection outcomes.
This PhD will investigate how nutrition and temperature influence the physiological costs and outcomes of viral infection in bumblebees using Acute Bee Paralysis Virus (Dicistroviridae) as a model. Combining expertise in insect nutritional physiology and behaviour (Nicholls Lab, University of Sussex) with experimental virology and virus-host interactions (Maringer Lab, The Pirbright Institute), the project asks how nutritional and temperature affect pathogen-host interaction, moving beyond conventional measures of infection and survival to identify the physiological mechanisms underlying resistance and tolerance to disease.
You will combine controlled artificial diets, experimental infections and temperature treatments with respirometry, thermal imaging and behavioural assays. Viral load and molecular markers of immune function will allow us to determine how nutritional balance and environmental stress affect antiviral responses, while metabolic measurements will reveal the energetic costs of mounting these responses. Targeted RNA interference may subsequently be used to test the contribution of specific immune pathways.
The project provides interdisciplinary training in virology, molecular biology, insect physiology, nutrition, behaviour, imaging and quantitative analysis. You will have substantial opportunity to shape the research according to your interests. Potential directions include comparing host responses to pathogens naturally associated with bumblebees and pathogens that have crossed from managed honeybees, and developing thermal imaging as a non-invasive indicator of infection and physiological stress. This interdisciplinary project will provide new insights into how environmental conditions determine the outcome of host–pathogen interactions, while improving understanding and prediction of pollinator resilience in changing environments.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Detection, Prevention and Intervention
Lead partner: University of Sussex
Supervisor: Rhys Morgan, rhys.morgan@sussex.ac.uk
Joint partner: UKHSA
Supervisor: Stuart Dent, Stuart.Dent@ukhsa.gov.uk
Project Summary
Arboviruses represent an emerging zoonotic public health threat internationally and to the UK. Severe human conditions caused by flaviviruses such as Zika, Dengue, Tick borne Encephalitis and West Nile viruses include microcephaly, severe joint pain, haemorrhagic fever and encephalitis. Although some effective vaccines are in production, there are no therapeutic interventions. The diversity of the family and emerging threat to the UK, necessitate that further preventative measures against these viruses are urgently required.
We, and others, have shown that canonical Wnt signalling can regulate the entry and infectivity of certain types of arbovirus, including Chikungunya. However, how widely this applies to other Arboviruses, and through which molecular mechanisms, remains unknown. Given that many Wnt signalling inhibitors such as PORCN inhibitors, pyrvinium pamoate and XAV939 have passed early clinical phase trials targeting other diseases (mainly human cancer) there is an exciting opportunity to repurpose/trial some of these agents in an antiviral setting.
Based at the University of Sussex, this study will use a variety of cellular and molecular assays to define the precise mechanisms through which Wnt signalling facilitates viral entry. Using non-infectious experimental models, the project will evaluate the effectiveness of a large range of Wnt inhibitors in preventing viral infection. Finally, the successful candidate will have the opportunity to test the most effective lead compounds and targeting mechanisms against a collection of flaviviruses and other arboviruses housed at the UK Health Security Agency (UKHSA) facility in Porton Down, Wiltshire.
In summary, this project will improve our understanding of how signal transduction pathways such as Wnt signalling contribute to viral entry, and identify the most effective small molecule inhibitors which could repurposed for antiviral deployment.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Understanding Disease Spread; Detection, Prevention and Intervention
Lead partner: University of Sussex
Supervisor: Dr Chris Hadjichrysanthou, C.Hadjichrysanthou@sussex.ac.uk
Joint partner: UKHSA
Supervisor: Dr Stephanie Evans, Stephanie.Evans@ukhsa.gov.uk
Project Summary
Respiratory viral infections remain a major public health challenge, particularly in healthcare and home-care settings where vulnerable individuals interact with healthcare workers, carers, patients and visitors. In such settings, transmission risk depends on an infected individual’s infectiousness, which varies over the course of infection and between individuals, the susceptibility of their contacts, and the timing, frequency and nature of interactions between them. Understanding how these processes interact across biological and population scales is essential for identifying the main drivers of transmission and designing effective interventions for disease control.
This PhD project will develop a multi-scale mathematical modelling framework linking within-host viral dynamics to individual infectiousness and population-level transmission. Using clinical, cohort and epidemiological data, the project will investigate how heterogeneity in viral dynamics, individual characteristics and contact patterns shapes transmission in structured environments, with particular emphasis on hospital and home-care settings. The framework will identify transmission pathways contributing disproportionately to disease spread and inform the optimal targeting of interventions.
Main components:
- Develop and calibrate within-host models of respiratory viral dynamics to characterise heterogeneity in viral-load trajectories between individuals and risk groups.
- Develop statistical models linking viral load and host characteristics to time-varying infectiousness, and incorporating recipient susceptibility to estimate the probability of transmission.
- Derive and estimate individual- and population-level reproduction numbers as functions of viral-load dynamics, host characteristics and contact patterns.
- Embed the within-host and infectiousness models within individual-based network transmission models of structured care environments to identify individuals, contact patterns and pathways contributing most strongly to infection introduction and onward transmission.
- Use the multi-scale framework to evaluate and optimise targeted interventions, including novel prophylactic and therapeutic treatments, and determine how interventions should be prioritised across individuals and settings.
The research will be jointly supervised with Dr Stephanie Evans and Dr Christopher Overton from UKHSA.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Microbial Evolution and Drug Resistance; Understanding Disease Spread
Lead partner: University of Sussex
Supervisor: Frances Pearl, f.pearl@sussex.ac.uk
Joint partner: The Pirbright Institute
Supervisor: Tim Downing, Tim.Downing@pirbright.ac.uk
Project Summary
Mutational signatures are characteristic patterns of DNA or RNA substitutions that provide clues to how genetic changes arise and accumulate. In cancer research, identifying these signatures in tumours has helped reveal the biological processes driving tumour development. This project brings the same approach to bacterial and viral pathogens, using genomic data to investigate the forces shaping pathogen evolution.
In this PhD you will analyse mutation patterns in bacterial and viral pathogens of livestock and birds, including those with zoonotic potential. Combining mutational signature analysis with comparative genomics and phylogenetics, you will investigate how biological and environmental influences, including antibiotic exposure, oxidative damage and host antiviral activity, shape pathogen evolution. Using APOBEC-mediated deamination in mpox as a case study, you will explore what these signatures can reveal about pathogen adaptation, transmission and disease, and how this knowledge could contribute to future outbreak risk assessment.
The project is computational. You will apply non-negative matrix factorisation (NMF) and explore emerging AI and machine-learning approaches to identify and quantify mutational patterns. You will learn to turn raw sequencing reads into assembled bacterial and viral genomes, develop reproducible analysis workflows and run them on a high-performance computing (HPC) system.
The project welcomes applicants from computing, mathematics, statistics and the life sciences. It will support computational applicants moving into biological research, as well as life scientists who can already program or want to develop coding and data-analysis skills. Alongside these technical skills, you will develop your ability to interpret complex data, communicate science and think critically while contributing to an emerging area of pathogen genomics with relevance to animal and human health.
A placement will provide hands-on training in next-generation sequencing (NGS), giving you practical experience of how the data you analyse are generated.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Infection and Cellular Biology; Detection, Prevention and Intervention
Lead partner: University of Sussex
Supervisor: Simon Waddell, s.waddell@bsms.ac.uk
Joint partner: UKHSA
Supervisor: Javier Salguero, Javier.Salguero@ukhsa.gov.uk
Project Summary
Why does it take six months of toxic multidrug therapy to successfully treat tuberculosis?
Tuberculosis (TB) is a respiratory disease caused by the bacterium Mycobacterium tuberculosis (M.tb) that kills 1.2 million people each year. The world needs new drugs and vaccines to eradicate this terrible disease. M.tb is able to survive both intracellularly and extracellularly in pulmonary lesions, which makes the bacteria very difficult to treat effectively with antibiotics. This project will characterise M.tb in relevant infection models using a combination of cutting-edge molecular tools, including genomics and transcriptomics. The project will lead to novel strategies to target M.tb by understanding the adaptations that M.tb bacilli undergo to survive and multiply in these lung microenvironments.
The project builds on an existing partnership between the University of Sussex (Waddell) and the UK Health Security Agency (UKHSA) Porton Down (Salguero and Hunter), where we have developed tools to profile M.tb (and host immune responses) from tuberculous lung lesions, mapping both spatial and temporal responses. The experienced supervisory team has expertise in the molecular microbiology of M.tb (Waddell), TB models of infection (Salguero), and the biology of lung granulomas (Hunter).
The project will: (1) Define M.tb adaptations (using transcriptomics and genomics) to life inside different types of lung granulomas; (2) Characterise the impact of these phenotypes on susceptibility to frontline antibiotics; (3) Use single-molecule fluorescence in situ hybridisation (smFISH) to map the spatial heterogeneity of M.tb in lung lesions; and (4) Identify targets for novel drug and vaccine discovery.
The project would suit a student who is interested in infection biology and in the application of molecular omics tools to drug and vaccine discovery. The student will be a member of active labs in Sussex and UKHSA, including the Centre of Infection and Antimicrobial Research (CINAMR).
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Microbial Evolution and Drug Resistance
Lead partner: University of Sussex
Supervisor: Leena Al-Hassan, l.al-hassan@bsms.ac.uk
Joint partner: Dstl
Supervisor: Nicole Britten, nbritten@mail.dstl.gov.uk
Project Summary
Antimicrobial resistance (AMR) is increasingly recognised as a One Health challenge driven not only by antibiotic use but also by environmental pressures that influence microbial adaptation, persistence and transmission. Metals such as iron, copper, zinc and manganese play important roles in bacterial physiology and host-pathogen interactions, regulating processes including biofilm formation and antimicrobial susceptibility. Environmental contamination arising from industrial activities, healthcare waste and conflict-related disruption may further increase exposure to selective metal pressures, potentially promoting the emergence and persistence of resistant bacterial populations. Growing evidence suggests that metal exposure may contribute to AMR through co-selection mechanisms, whereby genes conferring metal tolerance and antibiotic resistance are physically linked on plasmids and other mobile genetic elements. However, the extent to which metal exposure directly alters biofilm formation, antimicrobial tolerance and resistance evolution remains poorly understood.
This project will investigate how environmentally relevant metal exposure shapes the biology and evolution of clinically important pathogens associated with chronic wound infections, trauma-related infections and healthcare-associated outbreaks. Using a combination of biofilm phenotyping, antimicrobial susceptibility testing, experimental evolution and whole-genome sequencing, the project will determine whether metal exposure enhances biofilm-associated persistence, alters antibiotic susceptibility and promotes the emergence and maintenance of AMR determinants. Genomic analyses will examine the role of plasmids, integrons and other mobile genetic elements in the co-selection of metal tolerance and antimicrobial resistance traits.
The project has particular relevance to conflict-affected environments, where environmental contamination, damaged infrastructure and increased burdens of trauma may create conditions that favour the persistence and evolution of high-risk pathogens. By identifying the mechanisms linking environmental contamination, biofilm formation and antimicrobial resistance, this research will improve understanding of the ecological drivers of treatment failure and persistent infection.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Understanding Disease Spread
Lead partner: University of Sussex
Supervisor: Prof. Fiona Mathews, f.mathews@sussex.ac.uk
Joint partner: APHA
Supervisor: Lorraine McElhinney, lorraine.mcelhinney@apha.gov.uk
Project Summary
Bats make up about a third of all mammals, are exceptionally long lived, and have highly complex social lives. They are also important hosts of zoonotic pathogens, including lyssaviruses, a group of viruses that cause rabies. Given their extreme sociality and low reproductive rate, bats are good candidates for vaccination, yet very little is known about their ecology outside the summer maternity period. Key knowledge gaps include the location of hibernation sites, degree of contact between roosts in autumn and winter, roost sizes, and whether they perform swarming behaviour in autumn associated with mating. This hinders our understanding of the spread of European Bat Lyssavirus 1, a pathogen that is now being found over increasingly wide areas of England, following its first discovery in Dorset in 2018. New technologies, including miniaturised radiotags that use the Internet of Things (similar to ‘airtags’ for luggage), have been trialled by the research leaders with serotine bats. These tags have been able to identify previously unknown roosts and track movement pathways, and even detect co-roosting. The tags generate signals every 5 seconds, leading to very large datasets requiring, and the PhD will explore the use of AI to develop maps of movement patterns.
This PhD will therefore combine field ecology and advanced analysis of movement data to generate evidence on the spatial and temporal contact patterns of serotine bats, and apply it to understanding the risks of disease spread within serotine bats and potential transfer to humans and/or cats. Alternative management strategies can also be modelled. The project is particularly suited to candidates with an enthusiasm for understanding animal movements, and who want to combine field ecology with epidemiological research.
The project will benefit from an experienced and supportive supervisory team from Sussex (Mathews and Nouvellet), APHA (Mcelhinney) and Pirbright (Horton), combining expertise in bat ecology, movement analysis, epidemiology and virology, providing an exciting opportunity to work at the interface of an academic environment and a government agency.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Animal and Plant Health Agency (APHA)
Theme(s): Detection, Prevention and Intervention
Lead partner: APHA
Supervisor: John McGiven, john.mcgiven@apha.gov.uk
Joint partner: University of Surrey
Supervisor: Cristine Rollier, c.rollier@surrey.ac.uk
Project Summary
It is estimated that close to 1 million animals per year are used for antibody production in the EU alone, the majority are used for the generation of polyclonal sera. Such sera is often essential to support the detection, identification and control of pathogens and infectious disease. This project will support the reduction of animal usage by advancing the understanding of how animal free alternatives may meet this need. It will test the capability of cutting-edge polyclonal antibody sequencing technology as a means to generate highly specific antibodies and to reconstruct the properties of polyclonal sera though recombinant means.
The successful applicant will work alongside experienced and expert scientists at APHA’s WOAH Reference Laboratories for Salmonellosis and Brucellosis. They will affinity purify polyclonal antibody populations from existing and fresh stocks of animal serum using native, recombinant and synthetic protein and carbohydrate antigens derived from priority zoonotic Salmonella serovars and Brucella species. The applicant will not be required to undertake any animal work. The antibodies will be sequenced by commercial partners who will return the data to APHA for interpretation of the antibody response and the selection of sequences to take through for recombinant production (also done by commercial partners).
These will be screened against target pathogen antigens to identify their specificity and affinity. In some instances, a very precise epitope specificity will be required in order to identify a pathogen to serovar level. In others a blend of antibodies against a variety of epitopes on a target molecule and with a spectrum of affinities will be required to investigate how close such a cocktail comes to mimicking the key attributes of the original polyclonal sera. A successful outcome will enable an infinite animal free supply of critical products and contribute significantly to this emerging, important and exciting field.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Microbial Evolution and Drug Resistance
Lead partner: APHA
Supervisor: Dr Roderick Card, Roderick.Card@apha.gov.uk
Joint partner: University of Surrey
Supervisor: Professor Roberto La Ragione, r.laragione@surrey.ac.uk
Project Summary
Antimicrobial resistance (AMR) is a growing global health challenge affecting humans, animals and the environment. Low- and middle-income countries are expected to experience a disproportionate burden of AMR, yet important knowledge gaps remain regarding how resistant bacteria emerge, persist and spread between livestock, people and the wider environment. This project will investigate AMR in Escherichia coli from Nigeria using a One Health framework that integrates microbiology, genomics, epidemiology and disease control.
The PhD project will capitalise on unique collections of bacterial isolates and epidemiological data generated through established collaborations between APHA, the University of Surrey and Nigerian partner organisations. The student will analyse whole-genome sequencing data from E. coli isolated from livestock, farm workers and environmental sources to identify resistance mechanisms, explore genetic relationships between isolates, and investigate pathways of transmission. Epidemiological analyses will be used to examine associations between antimicrobial use, farm management practices, and the occurrence of resistant bacteria.
In parallel, selected bacterial isolates will be studied experimentally to assess characteristics linked to persistence and dissemination, including resistance to disinfectants and other interventions designed to reduce AMR emergence and spread. These investigations will provide evidence on the effectiveness of biosecurity and hygiene measures under conditions relevant to livestock production systems in Nigeria.
The project will deliver new insights into the drivers, transmission and control of AMR in livestock-associated E. coli. Findings will support evidence-based strategies to improve antimicrobial stewardship, strengthen biosecurity practices and inform policy development. The student will receive training in genomics, bioinformatics, epidemiology and laboratory-based research, while contributing to international efforts to tackle AMR and improve animal and human health through a One Health approach.
The student will benefit from an interdisciplinary training environment spanning two leading institutions: APHA (Roderick Card) and the University of Surrey (Roberto La Ragione and Abel Ekiri).
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Detection, Prevention and Intervention
Lead partner: APHA
Supervisor: Gerardo Aquino, Gerardo.Aquino@apha.gov.uk
Joint partner: University of Surrey
Supervisor: Joaquin Prada, j.prada@surrey.ac.uk
Project Summary
Early detection of emerging and previously unrecognised animal diseases is a key objective of national scanning-surveillance systems. Detecting novel threats is particularly challenging because their epidemiology, transmission dynamics and clinical presentation are initially unknown. Early evidence of emergence is often weak, dispersed and distributed across multiple surveillance sources rather than producing a clear signal within a single dataset. Such signals may appear as small deviations in diagnostic submissions, syndromic indicators, mortality records, production or performance measures, veterinary investigations, or other surveillance streams.
Multivariate surveillance has the potential to improve early detection by integrating information from multiple data sources to identify unusual patterns indicative of disease emergence. However, there is limited evidence regarding when multivariate approaches provide meaningful advantages over simpler surveillance systems and whether their additional complexity is operationally justified.
This PhD will develop and evaluate a framework for assessing the value of multivariate surveillance in detecting novel animal-disease threats, addressing the following objectives:
- Evaluate the ability of current surveillance systems to detect different classes of emerging disease threats and characterise how such threats generate signals across surveillance streams.
- Identify surveillance-system characteristics that influence multivariate performance, including reporting delays, inter-stream correlations, population coverage and signal strength.
- Determine when multivariate methods improve detection sensitivity, timeliness and reliability compared with conventional approaches.
- Develop practical guidance for surveillance-system design, including a framework identifying when multivariate surveillance provides a genuine operational advantage.
The project will compare approaches including multivariate control-chart methods such as MEWMA and MCUSUM¹, endemic-epidemic forecasting models², and Bayesian evidence-aggregation techniques³. Real surveillance data will be used to characterise baseline patterns, reporting behaviour and relationships between surveillance streams, informing realistic disease-emergence simulations and comparisons of multivariate, univariate and sentinel surveillance approaches.
Applications will include diseases such as avian influenza and Schmallenberg virus, as well as hypothetical Pathogen X scenarios. The research will provide evidence-based recommendations to strengthen animal-health surveillance and preparedness for emerging threats.
Additional co-supervision at APHA will be provided by Mark Arnold (Lead Mathematical Modeller), Richard Smith (Lead Analytical Epidemiologist) and Phil Jones (Lead Epidemiologist).
Further Information
Key references
- C. Faverjon, L.P. Carmo, J. Borowski, Prev Vet Med 2019 Nov 15:172:104778.
- L. Held et al Biostatistics. 2006 Jul;7(3):422-37
- R. Struchen, F., Vial, M.G. Andersson 2017, Scientific Reports, 7, 1191
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Detection, Prevention and Intervention
Lead partner: APHA
Supervisor: Muna Anjum, Muna.Anjum@apha.gov.uk
Joint partner: University of Surrey
Supervisor: Jennifer Ritchie, j.ritchie@surrey.ac.uk
CASE Partner: National Measurement Laboratory (NML)
Project Summary
This 4-year PhD CASE studentship offers an outstanding opportunity to tackle antimicrobial resistance (AMR), one of the biggest global health challenges using cutting edge metagenomics and AI
Accurate tools to detect and identify AMR are essential for guiding treatments, informing public health policies and protecting human, animal and environmental health. Current methods work well for single bacterial species, but robust approaches for complex microbial communities, and across a One Health framework, are only just emerging.
In this project, you will develop and validate metagenomic pipelines to identify and quantify AMR in bacterial communities from clinical, agricultural and environmental samples. Working with the National Measurement Laboratory (NML), you will help define measurement standards that make AMR surveillance data comparable and trustworthy across sectors and countries. You will also explore bioinformatics, machine learning and artificial intelligence approaches to improve detection and prediction of AMR.
You will be based primarily at the Animal and Plant Health Agency (APHA) in Weybridge, joining a vibrant cohort of researchers and postgraduates, and will spend defined placement periods at a new purpose-built laboratory at NML in the Surrey Research Park, Guildford. You will be supported by academic experts from the School of Biosciences at the University of Surrey, gaining advanced training in One Health, genomics, and AMR. The three locations lie within a 14-mile radius linked by public transport. In discussion with your supervisory team, your pattern of attendance across APHA, NML and the University will be planned flexibly to minimise day-to-day travel while maximising access to expertise and facilities.
This studentship is ideal for candidates with a strong background in microbiology, molecular biology or bioinformatics who are motivated to apply quantitative and computational approaches to real-world One Health challenges.
Apply now
Please apply by submitting an application form and completing our EDI survey.
The Pirbright Institute
Theme(s): Microbial Evolution and Drug Resistance; Understanding Disease Spread
Lead partner: The Pirbright Institute
Supervisor: Tim Downing, tim.downing@pirbright.ac.uk
Joint partner: University of Surrey
Supervisor: Bingxin Lu, b.lu@surrey.ac.uk
Project Summary
Poxviruses like mpox are a major threat to human and animal health. They possess flexible genomes, constantly evolving through mutation, recombination, and gene transfer to find new hosts and trigger new outbreaks. Thanks to recent advances in short- and long-read sequencing, we now have the high-resolution data needed to understand how these viruses adapt. However, there is a major bottleneck: poxvirus genomes are complex, repetitive, and constantly rearranging. The tools currently available to study them were designed for other non-viral organisms, leaving us with a key gap in viral genomics.
This PhD project is an opportunity to create and apply new viral evolutionary analysis tools. You will explore a diverse dataset of published poxvirus genomes and metadata while combining pangenome graphs and AI.
In this project, you will develop unsupervised machine learning models to analyse DNA similarity and pangenomic structures, training your models to discover new gene transfer and recombination events in understudied poxviruses. You will then extend your findings using advanced phylogenetic methods and comparing your results against existing tools.
This project is an excellent fit for a PhD student looking to do research the intersection of biology and computer science. You will receive hands-on training in machine learning, pangenomics, and viral genetics. Your work will create new computational foundations for understanding how complex viruses evolve, supporting the human and animal health community with tools needed to identify the genomic drivers of future outbreaks and pandemics.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Infection and Cellular Biology; Detection, Prevention and Intervention
Lead partner: The Pirbright Institute
Supervisor: Dr Trevor Sweeney, trevor.sweeney@pirbright.ac.uk
Joint partner: University of Surrey
Supervisor: Professor Carlos Maluquer de Motes, c.maluquerdemotes@surrey.ac.uk
Project Summary
Virus infection presents an evolutionary arms race with the host optimising anti-viral mechanisms while the virus evolves means of escape. All viruses must generate RNA during their replication cycle to produce viral proteins for replication and progeny virus generation. As such, RNA modification and sensing form key battle grounds in virus-host interactions. In this project the student will uncover how the host innate immune system targets these RNA pathways to prevent translation of viral proteins.
Exploiting viral systems of major global and pandemic concern, including flaviviruses (Dengue, Zika) and Mpox, the student will use gene editing approaches (knock down and knock out) to manipulate two RNA modification and sensing pathways (IFIT- and PARP-dependent) in cell-based systems and determine whether these key mechanisms of restriction are virus-specific or broadly target conserved steps in viral replication. The student will then address how these antiviral mechanisms operate mechanistically and characterise any viral antagonism strategy used by these pathogens.
Determining the mechanistic basis of host antiviral strategies is essential for developing novel antiviral strategies. Targeting key stages common to different viruses increases the potential of developing broad-spectrum antivirals active across multiple viral families. Further, understanding how viruses escape or manipulate host pathways can reveal new biology with potential for both infection control and more broadly improving human and animal health. The student will become expert in classical virology, RNA manipulation, in vitro reconstitution methods, bioimaging and cutting-edge virus-host interaction assays, mastering broadly transferable skills in cutting edge infection and immunity research applicable to careers in academia and industry.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Detection, Prevention and Intervention
Lead partner: The Pirbright Institute
Supervisor: Munir Iqbal, munir.iqbal@pirbright.ac.uk
Joint partner: University of Surrey
Supervisor: Oluwole O.Oni, o.oni@surrey.ac.uk
Project Summary
High pathogenicity H5 avian influenza viruses remain a major threat to poultry production and continue to pose a significant zoonotic risk. Although vaccination reduces disease and mortality, viral evolution and antigenic drift can compromise vaccine effectiveness, creating a need for rapidly deployable interventions that provide immediate protection and complement existing control measures.
This PhD project will develop innovative antibody-based approaches for the control of H5 avian influenza in poultry. The project builds on unique resources available at the Pirbright Institute, including a panel of more than 26 H5-specific nanobodies and a llama-derived nanobody library generated through immunisation against avian viral pathogens. Previous work from the group has demonstrated that engineered recombinant antibodies can reduce avian influenza disease and virus shedding in chickens, while therapeutic monoclonal antibodies have been characterised against emerging avian influenza viruses [PMID: 32121387; PMID: 36541801].
The project will identify broadly cross-reactive nanobodies targeting conserved H5 epitopes. In parallel, archived splenocytes from H5-infected and vaccinated chickens and ducks will be analysed using next-generation sequencing and single-cell approaches to recover immunoglobulin VH and VL sequences for the generation of novel H5-specific antibodies. Selected candidates will be engineered into multivalent and recombinant polyclonal-like formats capable of simultaneously targeting multiple viral epitopes, thereby enhancing breadth of protection and reducing the risk of viral escape.
Using computational biology, artificial intelligence, structural modelling, antibody engineering and virological assays, lead candidates will be evaluated for cross-reactivity and antiviral activity against contemporary H5 variants. A targeted chicken challenge study will provide proof-of-concept evidence of protection and reduced virus shedding. If time and resources permit, aerosol and drinking-water delivery systems will also be explored.
The project will generate novel antibody technologies that complement vaccination and strengthen future avian influenza control strategies.
Objectives and Approach
- Identify conserved H5 epitopes.
Approach: Sequence, structural and AI-based analyses of circulating H5 viruses. - Generate broadly protective multivalent antibodies
Approach: Screen llama-derived nanobody libraries and recover VH/VL sequences from immune chickens and ducks to engineer multivalent antibody constructs. - Assess breadth and escape potential
Approach: Computational prediction and laboratory evaluation of neutralisation breadth and escape mutations. - Evaluate efficacy in poultry-relevant models
Approach: Haemagglutination inhibition, virus-neutralisation and chicken respiratory epithelial assays. - Demonstrate proof-of-concept protection
Approach: Targeted chicken challenge study to assess protection and reduced viral shedding. - Explore delivery platforms (optional)
Approach: Investigate aerosol and drinking-water delivery for flock-level application.
Apply now
Please apply by submitting an application form and completing our EDI Survey.
Theme(s): Detection, Prevention and Intervention
Lead partner: The Pirbright Institute
Supervisor: Simon Graham, simon.graham@pirbright.ac.uk
Joint partner: University of Surrey
Supervisor: Amin Asfor, a.asfor@surrey.ac.uk
CASE partner: Zoetis
Project Summary
Current vaccines provide variable cross-protection against the extensive genetic diversity of circulating porcine reproductive and respiratory syndrome virus (PRRSV) strains. Structural vaccinology offers a promising strategy for the rational design of broadly protective vaccines through the identification of conserved neutralising epitopes. The isolation of monoclonal antibodies (mAbs) from immune pigs, whose sera are capable of broad neutralisation, provides the tools to identify these epitopes. We recently generated proof-of-principle data showing that neutralising mAbs can be isolated from hyperimmune pigs by baiting single B cells with recombinant PRRSV glycoproteins. Building on these data, this project aims to isolate a complete set of broadly neutralising mAbs and to define the epitopes they target.
The project will utilise next generation technologies, for example an antibody phage display library constructed using B cells from hyperimmune pigs. This library allows identification of antibodies that bind more complex native antigen structures. Isolated mAbs will be functionally screened for their ability to broadly neutralise strains spanning PRRSV genetic lineages and species. Antigen specificity will be determined using recombinant glycoproteins. Recognition of linear epitopes will be assessed using peptide libraries, whereas conformational epitopes will be mapped using deep mutational scanning with yeast surface display libraries. The final phase of the project will involve the engineering of virus-like particles displaying peptide epitopes or antigenic domains bearing conformational epitopes, and an evaluation of their ability to induce broadly neutralising antibodies.
This project will employ state-of-the-art technologies to support the design of a broadly protective PRRSV vaccine, reducing the impact of the most economically important pig disease. The project will be based at Pirbright and supervised by Simon Graham (Group Leader PRRS Immunology) and Dalan Bailey (Group Lead Viral Glycoproteins), and with additional supervision from Amin Asfor (Senior Lecturer Virology and Immunology) at Surrey and Zoetis, a global animal health company.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Infection and Cellular Biology; Microbial Evolution and Drug Resistance;
Lead partner: The Pirbright Institute
Supervisor: Toby Tuthill, toby.tuthill@pirbright.ac.uk
Joint partner: University of Surrey
Supervisor: Amin Asfor, a.asfor@surrey.ac.uk
Project Summary
The outer surface of a virus acts as both a protective shield to enable transmission of the viral genome to new hosts and a molecular key enabling entry into new host cells. The outer surface is also a target for neutralising antibodies and many viruses rapidly evolve to evade such attack.
Picornaviruses are a family of RNA viruses of humans (e.g. poliovirus) and animals (e.g. foot-and-mouth disease virus, FMDV). Their small size, simple non-enveloped capsid and rapid evolution makes them excellent models for understanding fundamental principles of virology.
This project will explore how the FMDV capsid balances requirements for virus assembly, entry into cells and escape from antibodies. The supervisory team have a long-standing interest in these areas of virology and with collaborators have recently developed an approach called deep mutational scanning (DMS). This exciting data-rich technique will be used to map capsid plasticity across capsid structure and function through the virus life cycle. Specific capsid mutations or regions of interest will be validated by the recovery of viruses engineered with relevant mutations and their characterisation in established assays for assembly and entry. DMS in presence of antibodies will investigate the evolutionary trajectories used by the virus to evade neutralising antibodies and experimental findings will be related to real-world evolution in collaboration with Pirbright’s FMD World Reference Laboratory.
The student will learn cutting edge virology, molecular biology and bioinformatics and be exposed to extensive collaborative networks within the host institutions, the UK and worldwide. FMD is a highly significant disease for global livestock agriculture with a $10B global annual burden. We anticipate data from this project will be reported in high-quality publications and will feed into larger collaborations to use artificial intelligence to predict capsid antigenicity, with significant impact for improving the selection of FMD vaccines.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Detection, Prevention and Intervention
Lead partner: The Pirbright Institute
Supervisor: Dalan Bailey, dalan.bailey@pirbright.ac.uk
Joint partner: University of Sussex
Supervisor: Edward Wright, ew323@sussex.ac.uk
Project Summary
Recent evidence from our laboratory, published in Nature, indicates that there are multiple bat alphacoronaviruses from Sub-Saharan Africa that have the potential to infect human cells. The two endemic human alphacoronaviruses, 229E and NL63, are also likely to have emerged from bat reservoirs on this continent at some point in human history.
However, the detailed evolutionary origin of these viruses and their ability to infect human cells remains unclear. Our overarching objective for this studentship is to ‘Understand the spillover risk of bat alphacoronaviruses in Sub-Saharan Africa’. In simpler terms, which viruses can jump into humans? The knowledge we acquire in this studentship will be used to develop candidate immunogens and therapeutics to these viruses before extensive spillover can occur, aiding global pandemic preparedness.
Initially, the project will focus on assay development and optimization, using existing global sequence databases to develop a library of lentiviral pseudotypes expressing KY43- (the CEACAM-6 using virus from Kenya we recently characterized), 229E- and NL63-related alphacoronavirus spikes, and examining their entry into cells. Subsequently, we will develop in-house monoclonal antibodies (derived from mouse immunizations), using these and polyclonal sera from human volunteers, to map the breadth of virus neutralization to related bat viruses. This information will be used to identify the relationship between genotype, antigenicity and immune escape, guiding vaccine development.
The PhD student, based at Pirbright – a National Virology Centre – and Sussex, will gain significant experience in molecular virology and immunology assays, cell biology and tissue culture techniques, whilst working in one of the most rapidly expanding fields in viral immunology (epitope mapping, multivalent vaccines and antigenic conservation). Supervision will be provided by an experienced team of virologists, cell biologists and immunologists and the student will be supported to publish, attend international conferences and build their network.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Infection and Cellular Biology; Microbial Evolution and Drug Resistance
Lead partner: The Pirbright Institute
Supervisor: Erica Bickerton, erica.bickerton@pirbright.ac.uk
Joint partner: University of Surrey
Supervisor: Jai Mehat, jw.mehat@surrey.ac.uk
CASE partner: Zoetis
Project Summary
This PhD project will investigate the complex interactions between avian coronavirus infectious bronchitis virus (IBV) and Avian Pathogenic Escherichia coli (APEC), two major pathogens that contribute significantly to disease burden and economic losses in the global poultry industry. While IBV is known to predispose chickens to secondary bacterial infections, the mechanisms by which viral infection promotes APEC colonisation, dissemination, and disease severity remain poorly understood. A better understanding of these interactions is essential for the development of more effective disease control strategies, improved vaccine design, and reduced reliance on antimicrobials.
The project will combine established and innovative in vitro and ex vivo approaches to investigate the synergistic dynamics of IBV-APEC co-infections across multiple mucosal sites. Using a well-established avian tracheal organ culture (TOC) model, the student will determine how IBV infection alters the respiratory mucosa and facilitates APEC colonisation and dissemination. Complementary nasal air-liquid interface (ALI) cultures will provide additional insight into virus-bacterial interactions within the upper respiratory tract. The project will also employ advanced three-dimensional “inside-out” chicken enteroids incorporating immune cell populations to investigate how enterotropic IBV disrupts intestinal barrier function and promotes bacterial infiltration. High-resolution microscopy will be used to visualise host-pathogen interactions, while metagenomic analyses of samples from IBV-infected chickens will identify virus-induced alterations to the gut microbiota that may enhance APEC colonisation and shedding. Together, these approaches will address key questions surrounding pathogenic strain combinations, host-pathogen interactions, and microbiome changes associated with co-infection.
Delivered through a collaboration between the University of Surrey and The Pirbright Institute, this project will provide training in virology, bacteriology, organoid systems, molecular biology, genomics, bioinformatics, and advanced imaging. The findings will generate fundamental knowledge of viral-bacterial co-infections in a One Health context, supporting the development of improved interventions for poultry health and welfare while helping to mitigate antimicrobial use. The student will gain a unique combination of laboratory and computational expertise, preparing them for careers in academia, industry, or science policy.
Apply now
Please apply by submitting an application form and completing our EDI survey.
UK Health Security Agency (UKHSA)
Theme(s): Microbial Evolution and Drug Resistance
Lead partner: UKHSA
Supervisor: Stephanie Evans, stephanie.evans@ukhsa.gov.uk
Joint partner: University of Sussex
Supervisor: Chris Hadjichrysanthou, c.hadjichrysanthou@sussex.ac.uk
Project Summary
Antimicrobial resistance (AMR) is a major global health challenge and is predicted to reduce life expectancy worldwide by almost two years by 2035. In England, AMR infections cost the NHS over £180 million annually and are associated with increased mortality and morbidity.
Exposure to antibiotics is a key driver of AMR at both the population and individual level. Most studies focus on short-term effects, examining resistance in the gut microbiota for months after antibiotic exposure. However, people receive multiple courses of antibiotics throughout their lives, and the cumulative impact of lifetime antibiotic exposure on resistance remains unclear. Understanding these long-term effects is essential for assessing interventions designed to reduce prescribing and for predicting future trends in AMR infections.
This PhD project will investigate the cumulative impact of antibiotic exposure on an individual’s risk of developing a resistant infection. Working with modellers and data scientists at UKHSA and the University of Sussex, you will combine population- and individual-level data on antibiotic prescribing and AMR to develop mathematical models of antibiotic use, AMR colonisation and infection across multiple scales. A key aspect of the project will be working with large, routinely collected UKHSA datasets, including data parsing, cleaning, quality assurance, linkage and curation across surveillance and prescribing sources. Using modern data science methods, you will transform complex real-world health data into research-ready assets that support advanced statistical analyses and mathematical modelling. The resulting models will capture microbiome, individual- and population-level impacts of antibiotic exposure and evaluate the effects of changes in antibiotic prescribing on AMR infections.
Main components:
i) Collate and analyse historical trends in antibiotic use to develop age-period-cohort models of antibiotic exposure and prescribing patterns.
ii) Construct and calibrate a multi-state model of within-host microbiome and colonisation dynamics to quantify the impact of antibiotic exposure on acquisition, clearance and selection of antimicrobial resistance.
iii) Integrate estimates from (ii) with population-level antibiotic exposure data from (i) to develop an age-structured compartmental transmission model that reproduces observed population trends in antimicrobial resistance.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Infection and Cellular Biology
Lead partner: UKHSA
Supervisor: Breeze Cavell, Breeze.Cavell@ukhsa.gov.uk
Joint partner: University of Surrey
Supervisor: Jorge Gutierrez-Merino, j.gutierrez@surrey.ac.uk
Project Summary
Mucosal surfaces represent a critical frontier of host defence, serving as the primary site of pathogen encounter and therefore the first line of protection. However, our understanding of mucosal immunity remains incomplete, including the physiological relevance of complement activation and mucosal antibodies. Emerging evidence increasingly points to their crucial role in preventing microbial infection through bactericidal killing and opsonophagocytic clearance. Furthermore, mucosal responses vary across bacterial species and among individual hosts, and the continuous interaction between the immune system and resident microbiota means that neither antibodies nor innate effectors are naïve at the time of pathogen exposure.
Objective: To characterise the impact of host-microbiota interactions on mucosal immune responses by assessing how antibody-mediated complement activation elicited by commensal bacteria shape protection against pathogenic bacteria.
Hypothesis: Prior antigenic experience at mucosal sites modulates immunity and therefore must be accounted for when studying bacterial clearance and rational vaccine design.
Project outline:
- Characterise functional capacity of phagocytes, including bacterial uptake, phagosome maturation and intracellular killing, following exposure to a panel of commensals representative of mucosal surfaces (e.g. Staphylococcus, Streptococcus, Lactobacillus).
- Determine whether commensal-conditioned phagocyte phenotypes show altered responses to opsonised pathogens of human and animal importance (e.g. Bordetella, Neisseria, GBS).
- Explore the mechanisms underlying any altered responses, such as innate immune signalling and phagocyte receptor expression.
Methods: Co-culture models/Transwell systems to better investigate interactions at the mucosal surface; flow cytometric opsonophagocytosis/antibody-mediated complement assays to unveil specific immune responses to bacteria; and reporter cells lines, gain- or loss- of function tests and advanced microscopy for the mechanistic studies.
Impact: Understanding how commensal bacteria shape mucosal phagocyte function could reveal new mechanisms of colonisation resistance and inform strategies to enhance protection against infections through vaccination or microbiome-targeted interventions.
Additional supervisors/collaborators: Stephen Taylor & Steve Thomas (UKSHA) and Carlos Maluquer de Motes (Surrey).
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Detection, Prevention and Intervention; Understanding Disease Spread
Lead partner: UKHSA
Supervisor: Dr Catherine Houlihan, catherine.houlihan@ukhsa.gov.uk
Joint partner: University of Surrey
Supervisor: Professor David Allen, d.j.allen@surrey.ac.uk
Project Summary
Recent implementation of metagenomic sequencing in routine clinical diagnostics has revealed unexpected zoonotic viral infections in the UK, including a confirmed London-acquired case of lymphocytic choriomeningitis virus (LCMV) encephalitis, a probable London-acquired Seoul orthohantavirus encephalitis, and a London-acquired avian paramyxovirus infection in an immunocompromised patient. These findings raise important questions about the frequency of zoonotic spillover events, the animal reservoirs involved, and the extent of undetected human exposure within the UK population.
This One Health PhD project will investigate whether these infections represent rare events or the visible tip of a larger, unrecognised burden of zoonotic disease. Focusing primarily on rodent-borne viruses, particularly LCMV and Seoul, the project will combine wildlife surveillance, diagnostic development, and human epidemiology to better understand zoonotic risk in Southern England.
The first phase, with co-supervision at APHA, will involve systematic sampling of rodent populations in inner London and rural comparator sites to determine the prevalence, distribution, and genetic diversity of zoonotic viruses circulating in wildlife reservoirs. Viral genomic analyses will be used to explore transmission dynamics and ecological factors associated with spillover risk.
Building on the findings, the student will develop and evaluate serological assays for LCMV and Seoul orthohantavirus at Porton Down, UKHSA. Addressing current diagnostic limitations will be essential for accurately measuring prior infection and exposure within human populations and will provide tools for future surveillance and outbreak investigations.
The newly developed assays will then be applied in targeted serosurveillance studies, leveraging existing collaborations including blood donor cohorts and residual specimen collections from a central London hospital. Comparing urban and rural populations will enable estimation of human exposure and assessment of risks to vulnerable groups, including immunocompromised individuals.
By integrating animal, human, and environmental health perspectives, this project will provide critical evidence to inform surveillance, preparedness, and public health policy for emerging zoonotic infections in the UK.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Detection, Prevention and Intervention
Lead partner: UKHSA
Supervisor: Emma Wise, emma.wise2@ukhsa.gov.uk
Joint partner: University of Sussex
Supervisor: Edward Wright, ew323@sussex.ac.uk
Project Summary
Can we make dangerous virus material safe to handle without destroying the very structures that make it useful?
This PhD will tackle that challenge at the interface of emerging virus preparedness, structural virology and diagnostic innovation. Based primarily at UKHSA Porton Down, the student will join a team at the forefront of developing X-ray inactivation technology for public-health use, with links to UKHSA’s WHO Collaborating Centre activities. The project will ask whether X-ray irradiation can generate non-infectious whole-virus reagents that retain native-like structure and antigenicity for diagnostics, assay validation, quality assurance and outbreak response.
Using three complementary hazard group 2 (HG2) virus systems: Hazara virus, Cedar virus and O’nyong-nyong virus, the student will define an X-ray “inactivation–preservation window”: the point at which infectivity is reliably lost while virion structure and antigenic integrity are retained. These viruses provide lower containment models relevant to Crimean-Congo haemorrhagic fever virus, Nipah/Hendra viruses and chikungunya virus.
The student will have the opportunity to collaborate with scientists at Diamond Light Source, including visits to eBIC to carry out experiments using world leading cryo-electron microscopy facilities to compare matched untreated and X-ray inactivated virions and determine whether irradiation alters particle morphology, membrane integrity and surface glycoprotein architecture.
Structural findings will be linked to antibody-binding assays and, in collaboration with the University of Sussex, pseudotyped-virus systems that test whether antibodies recognising preserved X-ray inactivated virions can also block viral entry. Pseudotypes bearing high-containment virus glycoproteins will further test how faithfully the HG2 systems reproduce antigenically important features of high-consequence pathogens.
By linking inactivation, structure, antigenicity and functional neutralisation, this project offers exceptional interdisciplinary training with direct relevance to safer virology, diagnostic preparedness and future outbreak response.
Additional supervisory support will be provided by Roger Hewson (UKHSA) and David Owen (Diamond Light Source)
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Detection, Prevention and Intervention
Lead partner: UKHSA
Supervisor: Ginny Moore, ginny.moore@ukhsa.gov.uk
Joint partner: University of Surrey
Supervisor: Jennifer Ritchie, j.ritchie@surrey.ac.uk
Project Summary
Water is essential to modern buildings, supporting heating, cooling, sanitation and hygiene. However, water systems are not sterile and naturally harbour microorganisms, which, while usually harmless, can cause serious infections in vulnerable individuals, particularly in healthcare settings.
Within plumbing systems, microorganisms form biofilms - complex communities that are highly resistant to conventional cleaning and disinfection. These biofilms can act as persistent reservoirs of opportunistic pathogens, causing prolonged healthcare-associated outbreaks and recurrent contamination of water outlets. Similarly, hospital sinks, drains and waste traps are recognised as important environmental reservoirs of antimicrobial resistant (AMR) bacteria. Current control measures are often ineffective, and even replacement of plumbing can be followed by rapid recolonisation. There is therefore an urgent need for innovative approaches to biofilm control in the built environment.
This PhD project will investigate the potential of phage-mediated biocontrol as a novel strategy for controlling biofilms within water and wastewater systems. Based at UKHSA Porton, the student will work with Dr Ginny Moore and Dr Matthew Wand within a vibrant public health research environment. They will also work closely with Dr Jennifer Ritchie’s research group at the University of Surrey, gaining access to specialist expertise and facilities for advanced biofilm imaging.
The student will isolate and characterise bacteriophages (viruses that specifically infect bacteria) and assess their ability to disrupt biofilms by targeting key pathogens and microbial "hub" species in laboratory-scale water and wastewater models. Using established fluorescence in situ hybridisation (FISH) microscopy methods, they will also visualise changes in biofilm structure and composition following phage and chemical treatments. The research will provide experience in microbiology, phage biology, advanced microscopy, water-system model development and data analysis, making it well suited to candidates interested in bacteriophages, environmental microbiology, biocontrol or infection prevention.
Ultimately, the research will evaluate phage-based interventions in a full-scale mock hospital at UKHSA Porton, providing a rare opportunity to test biofilm control strategies in a realistic healthcare environment.
Apply now
Please apply by submitting an application form and completing our EDI survey.
Theme(s): Understanding Disease Spread; Microbial Evolution and Drug Resistance
Lead partner: UKHSA
Supervisor: David Cleary, david.cleary@ukhsa.gov.uk
Joint partner: University of Surrey
Supervisor: Jennifer Ritchie, j.ritchie@surrey.ac.uk
Project Summary
Ruminant carriage of bacterial pathogens of humans is a well-established phenomenon. Deer are an understudied species with potential one-health importance, where incidences of Shiga Toxin-producing E. coli (STEC), a severe zoonotic gastrointestinal (GI) pathogen, have been observed. Usually this occurs through contaminated venison products, or through faecal contamination of crops, although sporadic, larger outbreaks do occur. GI carriage of other human pathogens including Clostridium sp., has also been detected. The extent to which a reservoir of human pathogens exists in deer and the prevalence of antimicrobial resistance (AMR) has been understudied, particularly in England. Advanced metagenomic techniques will allow exploration of the composition of the deer microbiome and the prevalence of associated human pathogens.
This PhD project has three aims:
- Identify prevalence of STEC and other human pathogens within deer to greater understand disease spread.
- Investigate the AMR genomic and evolutionary profile of pathogens within deer using phenotypic and metagenomic approaches.
- Characterise the deer GI microbiome.
This project will utilise both long and short read metagenomic approaches for microbiome analysis and pathogen identification. The student will develop valuable laboratory and bioinformatic skills, including microbiome analysis and pathogen genomics, amongst others, and will undertake fieldwork to collect and process samples.
The ideal student for this role will have an interest and experience in at least one of the following: basic microbiology and molecular biology laboratory research, metagenomics, microbiomes, ecology and/or fieldwork. An interest in developing bioinformatic skills is required, however full training will be provided.
The supervisory team will consist of Dr. David Cleary (lead supervisor, UKHSA), Dr. Jennifer Ritchie (joint supervisor, University of Surrey), Dr. Jack Hill (UKHSA) and Dr. Steven Pullan (UKHSA). The student will join a vibrant community of cutting-edge researchers across both the UKHSA and University of Surrey, and will be primarily based at UKHSA, Porton Down.
Apply now
Please apply by submitting an application form and completing our EDI survey.